Page 3 - Abvc News Today

Item 5.07 Submission of Matters to a Vote of Security Holders. On April 24, 2023, ABVC BioPharma, Inc. held its 2023 annual meeting of shareholders . At the Annual Meeting, the Companys... | April 24, 2023

Shares of BATM Advanced Communications Ltd. (LON:BVC – Get Rating) crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 27.25 ($0.34) and traded as low as GBX 22 ($0.27). BATM Advanced Communications shares last traded at GBX 23 ($0.29), with […]

ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Rating)’s stock price fell 1.6% during mid-day trading on Friday . The stock traded as low as $0.60 and last traded at $0.61. 36,441 shares changed hands during mid-day trading, a decline of 96% from the average session volume of 914,569 shares. The stock had previously closed at $0.62. […]

FREMONT, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology

By Chris Wack ABVC BioPharma Inc. shares more than doubled to $1.51 after the company said it was notified by the U.S. Food & Drug Administration that the Investigational New Drug... | January 5, 2023

Maxim Group lowered shares of ABVC BioPharma (OTCMKTS:ABVC – Get Rating) from a buy rating to a hold rating in a research note published on Wednesday, The Fly reports. ABVC BioPharma Stock Performance OTCMKTS ABVC opened at $0.74 on Wednesday. The stock’s fifty day moving average is $0.80 and its two-hundred day moving average is […]

FREMONT, CA, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - ABVC BioPharma, Inc. (Nasdaq: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology

FREMONT, CA, June 21, 2022 -- via NewMediaWire – ABVC Biopharma, Inc. , a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and... | June 21, 2022

BATM Advanced Communications (LON:BVC – Get Rating)‘s stock had its “house stock” rating restated by research analysts at Shore Capital in a research report issued on Friday, MarketBeat reports. BVC opened at GBX 51.40 ($0.67) on Friday. The business has a fifty day moving average of GBX 55.79 and a 200 day moving average of […]

Squarepoint Ops LLC purchased a new stake in shares of ABVC BioPharma, Inc. (OTCMKTS:ABVC – Get Rating) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 19,207 shares of the company’s stock, valued at approximately $44,000. Squarepoint Ops LLC owned approximately […]